This article describes perspectives of Medicare Advantage (MA) insurers about participating in the CMS value-based insurance design model test launched in 2017.
Sai Ma, PhD
Advertisement
Articles by Sai Ma, PhD
Advertisement
Latest Updated Articles
- All Things Considered, the Answer Is a Resounding Yes
Published: January 15th 2008 | Updated:
- Evidence for the Effect of Disease Management: Is $1 Billion a Year a Good Investment?
Published: December 1st 2007 | Updated:
- Insurers’ Perspectives on MA Value-Based Insurance Design Model
Published: July 18th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
How Medicaid Reforms Could Deepen State Coverage Gaps
3
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
4
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
5
